Quick Answer
LISATA THERAPEUTICS, INC. reported Gross Profit of $1.72 million for the year ending 2013.
- LISATA THERAPEUTICS, INC. showed a decrease of -27.7% in Gross Profit from 2012 to 2013.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 13, 2014.
- XBRL data for this metric is available from 2010 to 2013 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $6.50 million | Q3 2010: $5.24 million | Q1 2011: $5.31 million | Q2 2011: $420.1 thousand | Q3 2011: $285.7 thousand | Q1 2012: $817.0 thousand | Q2 2012: $636.1 thousand | Q3 2012: $686.5 thousand | Q1 2013: $131.8 thousand | Q2 2013: $124.4 thousand | Q3 2013: $731.0 thousand.
- Over the full 4 years of available data (2010 to 2013), LISATA THERAPEUTICS, INC.'s Gross Profit has declined by 91.5%.
- Historical annual values: Fiscal year 2013: $1.72 million | Fiscal year 2012: $2.38 million | Fiscal year 2011: $1.40 million | Fiscal year 2010: $20.15 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: